Finance

GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs

Apr 2, 2025 - 21:58
 0
Read More

Tags:

Previous Article

Arcus Biosciences: A High-Risk Speculation With Multiple Large, Near-Term Catalysts

Next Article

Waton Financial: Complex Structure Poses Downside Risk

Related Posts

Browser Startup Island Valued at $4.5 Billion in Coatue-Led Round

Browser Startup Island Valued at $4.5 Billion in Coatue...

Feb 8, 2025  0

Frank founder, chief growth officer convicted of fraud

Frank founder, chief growth officer convicted of fraud

Apr 1, 2025  0

Watch These Intel Stock Price Levels as Deal Speculation Mounts

Watch These Intel Stock Price Levels as Deal Speculatio...

Feb 18, 2025  0